Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rang in aandelen #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aandeelprijs
$0.21291741
Laatst gesynchroniseerd: 2025-04-18
Marktkapitalisatie
$12.07M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Categorie

Winst voor PCL, Inc. (241820)
Winst in Sep 2025 TTM: $-33.90M
Volgens de meest recente financiële verslagen van PCL, Inc. bedraagt de huidige winst van het bedrijf $-33.90M. In 2023 behaalde het bedrijf een winst van $-15.73M, een daling ten opzichte van de winst van 2022, die $-3.18M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van PCL, Inc. van 2015 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-33.90M -5.68%
2024 $-35.94M 128.48%
2023 $-15.73M 394.91%
2022 $-3.18M -88.07%
2021 $-26.64M -248.25%
2020 $17.97M -360.49%
2019 $-6.90M 33.10%
2018 $-5.18M 42.76%
2017 $-3.63M 87.03%
2016 $-1.94M 22.38%
2015 $-1.59M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.51B -22,254.56%
US
$5.15B -15,284.62%
US
$5.56B -16,508.71%
IE
$3.86B -11,488.46%
US
$1.42B -4,281.37%
US